Clues to be found in more personalized treatment for multiple myeloma can be found in the genetics of myeloma in each individual patient. Dr. Gareth Morgan and the UAMS Myeloma Institute in collaboration with the Dana Farber Cancer Institute and other institutions are working to collect genomic data from myeloma patients with the goal of segmenting patients into groups that could lead to more personalized therapy. Learn more about why this matters to you as a myeloma patient and how you can weigh in to help researchers come to conclusions faster. Listen Now
The Myeloma Genome Project with Dr. Gareth Morgan, UAMS Myeloma Institute
- Haematological cancer: Where are we now with the treatment of multiple myeloma?
- Altmetric: 5More detail Article | OPEN Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
- Trails and Tribulations
- Subaru and Leukemia & Lymphoma Society Blanket Myeloma Institute with Love
- From the Director